Compare Johnson & Johnson (JNJ) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Suncor Energy Inc. — how do they compare? Johnson & Johnson trades at $250.15 (market cap $598.96B), while Suncor Energy Inc. trades at $63.28 (market cap $72.86B). The key difference: Johnson & Johnson is far larger — about 8.2× Suncor Energy Inc.'s market cap, and Suncor Energy Inc. pays the higher dividend (2.71%). Which is the better fit depends on your goals.
| JNJ | SU | |
|---|---|---|
Market Cap | $598.96B | $72.86B |
Volume | 6,156,228 | — |
Sector | Health | Energy |
52-Week High | $267.24 | $69.73 |
52-Week Low | $164.36 | $38.17 |
Enterprise Value | $631.90B | $80.99B |
Dividend Yield | 2.15% | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
Suncor Energy (SU) trades at $62.62, up 0.3% with strong technical momentum and bullish analyst sentiment. The stock shows solid fundamentals with a P/E of 16.85, net income margin of 11.62%, and consistent earnings beats in recent quarters. Recent news highlights operational improvements and record production driving the stock's 49% annual gain. Cash flow remains positive with $166M net cash flow in 2025, supported by disciplined capital allocation.
SU presents a compelling investment case with attractive valuation metrics and strong institutional support, though exposure to oil price volatility and recent RSI overbought signals warrant caution. The company's integrated operations and shareholder returns provide stability, but investors should monitor commodity price trends and Q2 earnings results against the $2.14 EPS expectation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
